A comparative study between palonosetron and granisetron to prevent postoperative nausea and vomiting after laparoscopic cholecystectomy

Journal of Anaesthesiology Clinical Pharmacology

Volumn 26, Issue 4, 2010, Pages 480-483

  Bhattacharjee, Dhurjoti Prosad ^a   Dawn, Satrajit ^a   Nayak, Sushil ^a   Roy, Pramod Ranjan ^a   Acharya, Amita ^a   Dey, Ramkrishna ^a  

^a CALCUTTA NATIONAL MEDICAL COLLEGE   (India)

Author keywords

Granisetron; Laparoscopic surgery; Palonosetron; Postoperative Nausea and Vomiting(PONV)

Indexed keywords

EID: 81855214994     PISSN: 09709185     EISSN: 22312730     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Madej T, Simpsom K. Comparison of the use of domperidone, droperidol and metoclopramide in the prevention of nausea and vomiting following gynecological surgery. Br J Anaesth 1986; 58 : 879-83
2. Jellish WS, Leonetti JP, Sawicki K, et al. Morphine/ ondansetron PCA for postoperative pain, nausea and vomiting after skull base surgery. Otolaryngol Head Neck Surg 2006; 135: 175-81
3. Watcha MF, White PF. Postoperative nausea and vomiting: its etiology, treatment and prevention. Anesthesiology 1992; 77: 162-84
4. Blower PR. The role of specific 5-HT3 receptor antagonigm in the control of cytostatic drug-induced emesis. Euro J Cancer 1990; 26 (suppl. 1): s8-s11
5. Newberry NR, Watkins CJ, Sprosen TS, Blackburn TP, Grahame-Smith DG, Leslie RA. BRL 46470 potently antagonizes neural responses activated by 5-HT3 receptors. Neuropharmacology 1993; 32 : 729-735
6. Elliott P, Seemungal BM, Wallis Dl. Antagonism of the effects of 5-hydroxytryptamine on the rabbit isolated vagus nerve by BRL 43694 and metoclopramide. Naunyn-Schmiedebergs Archives of Pharmacology 1990; 341: 503-09
7. Rojas C, Stathis M, Thomas A, Massuda E, Alt J, Zhang J, Rubenstein E, Sebastianis S, Canloreggi S, Snyder SH, Slusher B. Palonosetron exhibits unique molecular interactions with the 5-HT3 receptor. Anesth Analg 2008; 107: 469-78
8. Gralla R, Lichinitser M, Vander Vegt S, Sleeboom H, Mezger J, Peschel C, Tonini G, Libianca R, Macciocchi A, Aapro M. Palonosetron improves prevention of chemotherapy induced nausea and vomiting following moderately emetogenic chemotherapy: results of a double-blind randomized phase 3 trial comparing single doses of palonosetron with ondansetron. Ann Oncol 2003; 14: 1570-7
9. Lerman J. Surgical and patient factors involved in postoperative nausea and vomiting. Br J Anaesth 1992; 69: 245-325
10. Bunce KT, Tyers MB. The role of 5-HT in postoperative nausea and vomiting. Br J Anaesth 1992; 69 (suppl. 1): S60-S62
11. R Janknegt et al. Clinical efficacy of antiemetics following surgery. Anaesthesia 1999; 54: 1059-68
12. Bermudez J, Boyle EA, Minter WD, Sanger GJ. The antiemetic potential of the 5-hydroxytryptamine 3 receptor antagonist BR 43694. Br J Cancer 1988; 58: 644-50
13. Carmichel J, Cantwell BMJ, Edwards CM, et al. A pharmacokinetic study of granisetron (BRI 43694A), a selective 5-HT3 receptor antagonist : correlation of antiemetic response. Cancer Chemother Pharmacol 1989; 24: 45-9
14. Furue H.Oota K, Taguchi T, Niitani H. Clinical evaluation of granisetron against nausea and vomiting induced by anticancer drugs : optimal dose finding study. J Clin Ther Med 1990 ; 6 : 49-61
15. Candiotti KA, Kovac AL, Melson Tl, Clerici G, Gan TJ. A randomized double-blind study to evaluate the efficacy and safety of three different doses of palono-setron versus placebo for preventing postoperative nausea and vomiting. Anesth Analg 2008; 107: 445-51
16. Kovac AL, Eberhart L, Kotarski J, Clerici G, Apfel C. A randomized double-blind study to evaluate the efficacy and safety of three different doses of palonosetron versus placebo for preventing postoperative nausea and vomiting over a 72 hour period. Anesth Analg 2008; 107: 439-44
17. Aspinall RL, Goodman NW. Denial of effective treatment and poor quality of clinical information in placebo controlled trials of ondansetron for postoperative nausea and vomiting: a review of published trials. BMJ 1995; 311: 844-6
18. Yarker YE, Mactavish D. Granisetron: an update of its therapeutic use in nausea and vomiting induced by antineoplasmic therapy. Drugs 1994; 48: 761-93